Aclaris announced that their
oral ATI-501 JAK 1/3 inhibitor Phase 2 clinical trials were successful in treating patients with alopecia areata (AA). No serious side effects reported.
https://investor.aclaristx.com/stati...5-a555a06cd866
Geen idee of dit ook werkt voor conventioneel haarverlies (AGA)